Submission Details
| 510(k) Number | K181195 FDA.gov |
| FDA Decision | Cleared SESE |
| Date Received | May 04, 2018 |
| Decision Date | November 02, 2018 |
| Days to Decision | 182 days |
| Submission Type | Traditional |
| Review Panel | Neurology (NE) |
| Summary | Summary PDF |
K181195 is an FDA 510(k) clearance for the ClearPoint System, a Neurological Stereotaxic Instrument, Real-time Intraoperative Mri (Class II — Special Controls, product code ORR), submitted by Mri Interventions, Inc. (Irvine, US). The FDA issued a Cleared decision on November 2, 2018, 182 days after receiving the submission on May 4, 2018. This device falls under the Neurology review panel. Regulated under 21 CFR 882.4560.
| 510(k) Number | K181195 FDA.gov |
| FDA Decision | Cleared SESE |
| Date Received | May 04, 2018 |
| Decision Date | November 02, 2018 |
| Days to Decision | 182 days |
| Submission Type | Traditional |
| Review Panel | Neurology (NE) |
| Summary | Summary PDF |
| Product Code | ORR — Neurological Stereotaxic Instrument, Real-time Intraoperative Mri |
| Device Class | Class II — Special Controls |
| CFR Regulation | 21 CFR 882.4560 |
| Definition | To Aid The Surgeon In Planning And Conducting General Stereotactic Neurosurgery In An Mri Suite. |